Nautic Partners, a middle-market private equity firm that focuses on three industries: healthcare, industrial products, and outsourced service, completed its acquisition of Mikart, a contract developer and manufacturer of solid dose and non-sterile liquid pharmaceuticals. Financial terms were not disclosed. Ongoing investments in the business including state-of-the-art serialization-compliant packaging lines enable Mikart to provide customers with the latest in CDMO offerings and capabilities, often years ahead of regulatory requirements and industry standards. “Nautic offers a compelling combination of healthcare, manufacturing and financial experience to help Mikart thrive and expand within the rapidly growing CDMO market. The work Miguel and Mikart’s management team have done to develop Mikart’s premier brand status in the market and a strong reputation amongst customers is impressive. We hope to build off this foundation and partner with existing and future clients to fill their CDMO needs.“ Mike Kallelis, Mikart CEO.